Dados B3 › KLBN11
KLBN11 (Klabin): has profit grown?
KLBN11 (Klabin): in 2024, net income attributable to controlling shareholders was R$ 1.8 billion, down 32% versus 2023 (a profit of R$ 2.7 billion); five years earlier (2019), a profit of R$ 675.8 million.
| Year | Profit (loss) | Change |
|---|---|---|
| 2024 | R$ 1.8 billion | down 32% |
| 2023 | R$ 2.7 billion | down 43% |
| 2022 | R$ 4.7 billion | up 55% |
| 2021 | R$ 3.0 billion | a turn from loss to profit |
| 2020 | -R$ 2.5 billion | a turn from profit to loss |
| 2019 | R$ 675.8 million | up 392% |
| 2018 | R$ 137.5 million | down 74% |
| 2017 | R$ 532.2 million | down 79% |
| 2016 | R$ 2.5 billion | a turn from loss to profit |
| 2015 | -R$ 1.3 billion | — |
Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/KLBN11/fatos - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: KLBN11.
Dividends · Debt · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:14 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:14 UTC. If this does not match /saude, you are reading a cached copy.